
Sign up to save your podcasts
Or


In this episode, we analyze Nvidia's bold investment of $50M in Recursion, a trailblazer in AI-driven drug discovery, examining the synergies between Nvidia's technology and Recursion's innovative approach to pharmaceutical research.
Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: https://AIBox.ai/
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
By Fearless AIIn this episode, we analyze Nvidia's bold investment of $50M in Recursion, a trailblazer in AI-driven drug discovery, examining the synergies between Nvidia's technology and Recursion's innovative approach to pharmaceutical research.
Invest in AI Box: https://Republic.com/ai-box
Get on the AI Box Waitlist: https://AIBox.ai/
AI Facebook Community
Learn more about AI in Music
Learn more about AI Models
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.